Attenuation of Cerebral Venous Contrast in Susceptibility-Weighted Imaging of Spontaneously Breathing Pediatric Patients Sedated with Propofol

References

1. 1.↵
   1. Haacke EM,
   2. Xu Y,
   3. Cheng YC,
   4. et al

   . Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–18

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Reichenbach JR,
   2. Venkatesan R,
   3. Schillinger DJ,
   4. et al

   . Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272–77

   PubMedWeb of Science
3. 3.↵
   1. Ogawa S,
   2. Lee TM,
   3. Kay AR,
   4. et al

   . Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990;87:9868–72

   Abstract/FREE Full Text
4. 4.↵
   1. Sedlacik J,
   2. Rauscher A,
   3. Reichenbach JR

   . Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels. Magn Reson Med 2007;58:1035–44

   CrossRefPubMed
5. 5.↵
   1. Kety SS,
   2. Schmidt CF

   . The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Invest 1948;27:484–92

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Rauscher A,
   2. Sedlacik J,
   3. Barth M,
   4. et al

   . Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging. Magn Reson Med 2005;54:87–95

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Cameron OG,
   2. Modell JG,
   3. Hariharan M

   . Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci 1990;47:1141–46

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Sedlacik J,
   2. Helm K,
   3. Rauscher A,
   4. et al

   . Investigations on the effect of caffeine on cerebral venous vessel contrast by using susceptibility-weighted imaging (SWI) at 1.5, 3 and 7 T. Neuroimage 2008;40:11–18

   CrossRefPubMed
9. 9.↵
   1. Fox PT,
   2. Raichle ME

   . Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci U S A 1986;83:1140–44

   Abstract/FREE Full Text
10. 10.↵
    1. Hoge RD,
    2. Atkinson J,
    3. Gill B,
    4. et al

    . Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson Med 1999;42:849–63

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Tong KA,
    2. Ashwal S,
    3. Obenaus A,
    4. et al

    . Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008;29:9–17

    Abstract/FREE Full Text
12. 12.↵
    1. Mallory MD,
    2. Baxter AL,
    3. Kost SI

    . Propofol vs pentobarbital for sedation of children undergoing magnetic resonance imaging: results from the Pediatric Sedation Research Consortium. Paediatr Anaesth 2009;19:601–11

    PubMed
13. 13.↵
    1. Pershad J,
    2. Wan J,
    3. Anghelescu DL

    . Comparison of propofol with pentobarbital/midazolam/fentanyl sedation for magnetic resonance imaging of the brain in children. Pediatrics 2007;120:e629–e636

    Abstract/FREE Full Text
14. 14.↵
    1. Kaisti KK,
    2. Langsjo JW,
    3. Aalto S,
    4. et al

    . Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 2003;99:603–13

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Fox J,
    2. Gelb AW,
    3. Enns J,
    4. et al

    . The responsiveness of cerebral blood flow to changes in arterial carbon dioxide is maintained during propofol-nitrous oxide anesthesia in humans. Anesthesiology 1992;77:453–56

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Karsli C,
    2. Wilson-Smith E,
    3. Luginbuehl I,
    4. et al

    . The effect of nitrous oxide on cerebrovascular reactivity to carbon dioxide in children during propofol anesthesia. Anesth Analg 2003;97:694–98

    PubMedWeb of Science
17. 17.↵
    1. Van Aken H,
    2. Van Hemelrijck J

    . Influence of anesthesia on cerebral blood flow and cerebral metabolism: an overview. Agressologie 1991;32:303–06

    PubMed
18. 18.↵
    1. Karsli C,
    2. Luginbuehl I,
    3. Bissonnette B

    . The cerebrovascular response to hypocapnia in children receiving propofol. Anesth Analg 2004;99:1049–52

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Iwama H,
    2. Nakane M,
    3. Ohmori S,
    4. et al

    . Propofol dosage achieving spontaneous breathing during balanced regional anesthesia with the laryngeal mask airway. J Clin Anesth 2000;12:189–95

    CrossRefPubMed
20. 20.↵
    1. Brian JE Jr.

    . Carbon dioxide and the cerebral circulation. Anesthesiology 1998;88:1365–86

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Ashkanian M,
    2. Borghammer P,
    3. Gjedde A,
    4. et al

    . Improvement of brain tissue oxygenation by inhalation of carbogen. Neuroscience 2008;156:932–38

    CrossRefPubMed
22. 22.↵
    1. Kesavadas C,
    2. Thomas B,
    3. Misra S,
    4. et al

    . Attenuation of cerebral veins in susceptibility-weighted MR imaging performed with the patient under general anesthesia. AJNR Am J Neuroradiol 2008;29:e71
23. 23.↵
    1. Essig M,
    2. Reichenbach JR,
    3. Schad LR,
    4. et al

    . High-resolution MR venography of cerebral arteriovenous malformations. Magn Reson Imaging 1999;17:1417–25

    CrossRefPubMed
24. 24.↵
    1. Amemiya S,
    2. Aoki S,
    3. Takao H

    . Venous congestion associated with developmental venous anomaly: findings on susceptibility weighted imaging. J Magn Reson Imaging 2008;28:1506–09

    CrossRefPubMed
25. 25.↵
    1. Mentzel HJ,
    2. Dieckmann A,
    3. Fitzek C,
    4. et al

    . Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography. Pediatr Radiol 2005;35:85–90

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Juhasz C,
    2. Haacke EM,
    3. Hu J,
    4. et al

    . Multimodality imaging of cortical and white matter abnormalities in Sturge-Weber syndrome. AJNR Am J Neuroradiol 2007;28:900–06

    Abstract/FREE Full Text
27. 27.↵
    1. Newbern MS,
    2. Jacobson JP,
    3. Oyoyo U,
    4. et al

    . Cyanotic heart disease is associated with increased prominence of cerebral deep medullary veins on susceptibility-weighted imaging in children undergoing evaluation for heart transplantation. American Society of Neuroradiology 47th Annual Meeting, Vancouver, British Columbia, Canada, May 16–21, 2009, scientific poster 206, pp. 400–01
28. 28.↵
    1. Broniscer A,
    2. Gajjar A

    . Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 2004; 9: 197– 206

    Abstract/FREE Full Text
29. 29.↵
    1. Wedge SR,
    2. Ogilvie DJ,
    3. Dukes M,
    4. et al

    . ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Cancer Res 2002;62:4645–55

    Abstract/FREE Full Text
30. 30.↵
    1. Luh WM,
    2. Wong EC,
    3. Bandettini PA,
    4. et al

    . QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999;41:1246–54

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Wang J,
    2. Alsop DC,
    3. Li L,
    4. et al

    . Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 2002;48:242–54

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Begg CB

    . Statistical methods in medical diagnosis. Crit Rev Med Inform 1986;1:1–22

    PubMed
33. 33.↵
    1. Lipsitz SR,
    2. Laird NM,
    3. Harrington DP

    . Generalized estimating equations for correlated binary data: using the odds ratio as a measure of association. Biometrika 1991;78:153–60

    Abstract/FREE Full Text
34. 34.↵
    1. Mercadante S,
    2. Ferrera P,
    3. Villari P,
    4. et al

    . Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer. J Palliat Med 2009;12:60–63

    CrossRefPubMed
35. 35.↵
    1. Biagi L,
    2. Abbruzzese A,
    3. Bianchi MC,
    4. et al

    . Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J Magn Reson Imaging 2007;25:696–702

    CrossRefPubMed
36. 36.↵
    1. Wu CH,
    2. Chou HC,
    3. Hsieh WS,
    4. et al

    . Good estimation of arterial carbon dioxide by end-tidal carbon dioxide monitoring in the neonatal intensive care unit. Pediatr Pulmonol 2003;35:292–95

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Panerai RB,
    2. Deverson ST,
    3. Mahony P,
    4. et al

    . Effects of CO₂ on dynamic cerebral autoregulation measurement. Physiol Meas 1999;20:265–75

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Packard SD,
    2. Mandeville JB,
    3. Ichikawa T,
    4. et al

    . Functional response of tumor vasculature to PaCO₂: determination of total and microvascular blood volume by MRI. Neoplasia 2003;5:330–38

    PubMedWeb of Science
39. 39.↵
    1. Tong KA,
    2. Ashwal S,
    3. Holshouser BA,
    4. et al

    . Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003;227:332–39

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Gemma M,
    2. de Vitis A,
    3. Baldoli C,
    4. et al

    . Functional magnetic resonance imaging (fMRI) in children sedated with propofol or midazolam. J Neurosurg Anesthesiol 2009;21:253–58

    CrossRefPubMed
41. 41.↵
    1. Souweidane MM,
    2. Kim KH,
    3. McDowall R,
    4. et al

    . Brain mapping in sedated infants and young children with passive-functional magnetic resonance imaging. Pediatr Neurosurg 1999;30:86–92

    CrossRefPubMedWeb of Science